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Information Section  2). However, the latter task is made 
difficult as a result of the complex chemical nature of lipids 
and their ubiquitous presence in multiple roles in biological 
tissues. In addition, the identification of many lipid molec-
ular species is complicated by the high number of structural 
isomers corresponding to a given lipid mass. Although 
some low-throughput mass spectrometry techniques lead 
to precisely defined molecular structures (Nguyen et  al. 
2015), there is still more technical development needed 
before this can be applied in a routine way to global lipi-
domics. Pathways of lipid metabolism are both complex 
and often not fully understood: some reactions are not well 
characterized; some metabolites are not endogenously syn-
thesised but enter through the diet (Holmes et  al. 2008); 
and many enzymes have low substrate specificity, allow-
ing them to accept a huge range of fatty acids and alcohols 
as substrates (Gibellini and Smith 2010). In addition, most 
biological and clinical scientists refer to lipids by com-
mon and often inconsistent names, rather than a systematic 
naming scheme, which can lead to confusion. These fac-
tors together make it difficult to automate the construction 
and analysis of metabolic pathways and networks, and a 
basic requirement for progress is to define a mechanism for 
resolving synonyms and one-to-many relationships in lipid 
identities (Horne et al. 2004).
Most recent lipidomics papers conclude their study with 
a list of the lipids that were found to be significantly dif-
ferent between two groups, for example between diseased 
and healthy tissue or between treated and control samples. 
However, there is a small number of examples that go one 
step further. For example, one can create and test a predic-
tive model (Floegel et al. 2013), apply advanced statistics to 
classify profiles into high or low risk of suffering a disease 
(Rhee et al. 2011), manually construct a network between 
known disease-associated genes, signal-transduction 
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Introduction It is difficult to elucidate the metabolic and 
regulatory factors causing lipidome perturbations.
Objectives This work simplifies this process.
Methods A method has been developed to query an online 
holistic lipid metabolic network (of 7923 metabolites) to 
extract the pathways that connect the input list of lipids.
Results The output enables pathway visualisation and the 
querying of other databases to identify potential regulators. 
When used to a study a plasma lipidome dataset of polycys-
tic ovary syndrome, 14 enzymes were identified, of which 3 
are linked to ELAVL1—an mRNA stabiliser.
Conclusion This method provides a simplified approach 
to identifying potential regulators causing lipid-profile 
perturbations.
1 Introduction
Recent advances in analytical methods, especially mass 
spectrometry, have shown that complex lipid profiles can 
be influenced by many factors and have the potential to 
improve our understanding of the pathophysiology underly-
ing disease processes (references listed in Supplementary 
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pathways and the perturbed levels of specific lipids (Wang-
Sattler et  al. 2012), or colour-code pathway or network 
maps from databases such as the Kyoto Encyclopedia of 
Genes and Genomes (KEGG) (Cottret et  al. 2010; Titz 
et al. 2015).
In this work, we propose a method of systematically con-
verting lists of perturbed lipids to integrate them with met-
abolic network which permits visualisation of the affected 
pathways. This process involves four steps, the first two 
involving the construction of a network (that links enzymes 
and hence genes to reactions between specific lipids) and a 
thesaurus (linking generic lipid identifiers to a list of possi-
ble specific metabolites). The second two steps involve the 
implementation of algorithms to generate the subset of the 
total network that corresponds to the input profile of per-
turbed lipids, and to rank enzyme nodes in terms of their 
significance to the perturbation. As a proof of concept, we 
apply this method to a published lipidomics dataset .
2  Methods
2.1  Data sources
Source data for creating the holistic human lipidomic net-
work included LIPID MAPS (Sud et  al. 2007), KEGG 
(Kanehisa 1996), HMDB (Wishart et  al. 2013) and other 
papers cited in Supplementary Information Section 3.
2.2  Network construction
The lipid metabolic network was created using Python 
scripts applied to data from the above sources, plus manual 
curation, and has been stored in a mySQL database. All 
scripts can be obtained from https://github.com/Ferran-
Casbas/Lipid-Pathway. The network contains a metabo-
lite node for each specific lipid, but does not distinguish 
between the fatty-acyl groups at the sn-1 and sn-2 chain 
positions to limit the network size and complexity and 
because analytical resolution of sn-1/sn-2 sidechains is 
rarely achieved across the whole lipidome. Other nodes 
may refer to individual reactions, and the enzymes (speci-
fied by their Human Genome Identifier) catalysing them. 
Further details are in the Supplementary Information 
Section 4.
2.3  Subset generation
The whole process is depicted in Fig. 1. The input used is 
a list of lipids whose concentrations are significantly higher 
or lower between two groups, determined for example 
after univariate or multivariate data analysis of a lipidom-
ics dataset and the structural confirmation of the chemical 
identities of the changed lipids. Lipid names should con-
form to the standard in LIPID MAPS (http://www.lipid-
maps.org/data/classification/lipid_cns.html#N). The pre-
ferred level of identification is to include the lipid class 
and the numbers of carbons and double bonds in each side 
chain. For example, this approach can include ambiguously 
identified molecules such as DG(36:2) which indicates a 
diglyceride with two side chains totalling 36 carbons with 
2 double bonds. The fold change or significance score for 
the metabolites (often the VIP scores from Partial Least 
Squares analysis) can also be input and used for meta-
bolic prioritisation. Alternatively, +1 and −1 can be used 
to imply the direction of change in lipid level between one 
group and another.
PHP scripts then use the list to produce a subgraph (sub-
network). The first phase of the analysis works through 
the list to identify specific, ambiguous and unrecognisable 
terms. The software reports on this and recommends what 
might be done to clarify the unrecognised terms. Once the 
lipids of interest have been adequately associated with net-
work nodes, a sub-network is generated by selecting from 
the lipidomic network these nodes and their two nearest 
neighbours, so that the reactions and enzyme/genes link-
ing these lipids are also included. If the input lipids have 
fold change or significance scores, the output sub-network 
contains Relative Importance scores, which indicate how 
much influence the enzyme nodes have on producing the 
observed lipid-profile perturbation in light of the network 
topology. This can be particularly valuable when larger 
sub-networks are returned. More information on this is in 
Supplementary Information Section 6.
The above scripts are available through a web inter-
face, which can be found at: http://lipidnetwork.notting-
ham.ac.uk/. The web tool outputs two files which can be 
imported into a network visualization software, such as 
Cytoscape (Doerks et al. 2002), to see the metabolic path-
ways involved in the profile changes. Another option is to 
open the node-info file in a spreadsheet to retrieve the list 
of enzymes, which can then be used as a query to other 
network tools, such as the BioGRID (Stark et al. 2006) or 
genemania, to identify potential regulators.
3  Results and discussion
This work describes a novel method for identifying 
enzymes and potential regulators related to measured 
changes in the lipid profile obtained from mass spectrom-
etry analysis. The method includes the development of a 
holistic lipidomic network that comprises 127 enzymes, 
13,934 reactions and 7561 metabolites. The latter are from 
16 lipid subclasses: 3124 glycerolipids, 3575 glycerophos-
pholipids, 290 sphingolipids, 126 fatty acyls (including 
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eicosansoids, fatty amides, esters and their conjugates), 
and 446 miscellaneous lipids. An image of the complete 
network can be seen in Supplementary Fig. 1, and further 
details of the network’s properties are described in Sup-
plementary Tables  1–3. The Supplementary Information 
Section  9 outlines extensions to this method that can be 
carried out by suitably experienced bioinformaticians.
To show the power and utility of the method, it has been 
applied to a published dataset that contains lipid profile for 
women with polycystic ovary syndrome (PCOS) compared 
Fig. 1  The Lipid network method. a Input list of lipids with OPLS-
DA model scores. b Depicts the web server that contains scripts 
and the lipidomic network, in which node colours green, dark blue, 
orange, red and white respectively correspond to glycerophospho-
lipids, sphingolipids, diglycerides, enzymes and specific reactions. 
c Derived subset of lipid metabolism linking the input perturbed 
metabolites; metabolite, reaction and enzyme nodes are respectively 
represented by rectangles, triangles and ellipses; input metabolite 
nodes are respectively coloured a brighter shade or green or red 
depending on the extent to which their levels have been elevated or 
decreased, or blue if they correspond to nodes introduced during 
the subset retrieval; the borders of enzyme nodes are shaded blue or 
red respectively to depict the extent of positive or negative Relative 
Importance Score (the sign corresponding to the increase or decrease 
in enzyme activity). d The list of retrieved enzymes ranked by Rela-
tive Importance
 F. Casbas Pinto et al.
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with matched controls (2). The contribution score of the 
lipids found in significantly different concentration was 
assigned from an OPLS-DA analysis (see Fig.  1). The 
output .sif and node-attributes files were imported into 
Cytoscape and the nodes manually stacked to aid visual 
interpretation of the network. This allows us to view the 
enzymes that have a higher impact on the profile.
In this example, 14 enzymes have been retrieved falling 
into two separate components, with the highest in absolute 
value of Relative Importance scores being for PLD1 (a 
phosphatidylcholine-specific phospholipase) and Chpt1 (a 
choline phosphotransferase). This suggests that the changes 
in plasma lipid profile associated with PCOS may be domi-
nated by a reduction in Chpt1 activity and/or an increase in 
PLD1 activity. The former is responsible for changes in DG 
and PC, and PLD1 is responsible for changes in PE and PC. 
Since there is equilibrium between the PA and DG species, 
a simple hydrolysis would convert one into the other, the 
perturbation of Pld1 could by itself explain the majority of 
observed changes.
The list of enzymes provided by this metabolic insight 
can be used to query other biomolecular network tools to 
identify potential common regulators of these lipids. 11 of 
them were present in BIOGRID, 4 linked by ELAVL1 and 
2 by ILF3, which both protect target mRNAs from degra-
dation (see Supplementary Fig. S7). Querying GeneMania 
revealed consistent patterns for regulation of Chpt1 and 
Pisd by microRNAs recognising the target sequence TGC 
TTG CT, and Dgkz, Ppap2a and Smpd1 by the transcription 
factors MAZ, NFAT and STAT5B (Supplementary Fig. 
S8). Unfortunately, both regulators have an enzyme whose 
activity goes in the opposite direction to the rest, so it is 
difficult to assert any strong hypotheses at this stage.
4  Conclusions
To conclude, the methodology presented here provides a 
way to move from tables of perturbed lipid levels to a visu-
alization of the metabolic network that could cause these 
changes and thence to potential regulators. It also provides 
a metric (Importance) to rank the positive or negative con-
tribution of each enzyme to produce the changes seen.
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